How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression.
Antônio Geraldo da Silvam and Anderson Gobbi
Dr. Antônio Geraldo da Silva is a psychiatrist, researcher, and president of the Brazilian Psychiatric Association (ABP). He is a nationally recognized voice in Brazil’s mental health field and a leading advocate for ethical innovation and equitable access to care. Dr. Geraldo has co-led several pioneering initiatives that apply artificial intelligence to psychiatric diagnosis and treatment personalization. He is also co-authoring a forthcoming book on the practical use of AI in mental healthcare.
Anderson Gobbi is a senior leader at Microsoft and co-founder of XPDoctor, a Brazilian healthtech company focused on digital mental health innovation. With over 20 years of experience in technology, business continuity, and AI deployment, he leads strategic initiatives to integrate clinical decision support and data science in psychiatry. Anderson also collaborates with academic institutions to promote responsible AI adoption in healthcare across Latin America.